Back

A-CLOSE: Clopidogrel vs Extended DAPT after High-Risk PCI

29 August 2026 (11:45 - 11:55)
Organised by: Logo
Congress Presentation Part of: HOT LINE 3 Adjunctive Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Byeong-Keuk Kim

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

14 More presentations in this session

Presentation thumbnail
LIBREXIA ACS: Milvexian after recent ACS
Professor P. Steg (Paris, FR)
Slides Video
Presentation thumbnail
Discussant review - LIBREXIA ACS
Professor M. Sabatine (Boston, US)
Slides Video
Presentation thumbnail
Panel discussion - LIBREXIA ACS
Presentation thumbnail
PREMIUM: Aspirin Omission at the Time of Primary PCI in STEMI
Doctor G. Nakazawa (Osaka, JP)
Slides Video
Presentation thumbnail
Discussant review - PREMIUM
Professor M. Valgimigli (Lugano, CH)
Slides Video

Access the full session

Session thumbnail
HOT LINE 3
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 11:45 CET
You may be interested in
thumbnail
Congress Session
HOT LINE 7
31 August 2025
thumbnail
Congress Presentation
Extended clopidogrel monotherapy versus DAPT in high-risk patients: the OPT-BIRISK trial
28 August 2023
thumbnail
Congress Session
Ask the Trialists - A-CLOSE
29 August 2026
thumbnail
Congress Presentation
Clopidogrel versus aspirin monotherapy for secondary prevention after percutaneous coronary intervention - a nationwide population-based study
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources